AccessMyLibrary provides FREE access to over 30 million articles from top publications available through your library.
Create a link to this page
Copy and paste this link tag into your Web page or blog:
Clinical Trial Data for Perforomist(TM) Inhalation Solution to be Presented at ATS on May 20, 2007.
-- Data from Phase III pivotal trial demonstrate safety and efficacy of first FDA-approved nebulized formoterol fumarate for patients with moderate to severe COPD --
NAPA, Calif., May 16 /PRNewswire/ -- Dey, L.P. announced that two clinical data presentations will be given at the International Conference of the American Thoracic Society (ATS) on Sunday, May 20, at the Moscone Center in San Francisco. The presentations will detail Phase III clinical data demonstrating the safety and efficacy of Perforomist(TM) (formoterol fumarate) Inhalation Solution, approved on May 11 by the FDA for long-term, twice-daily maintenance treatment of bronchoconstriction for emphysema and chronic bronchitis, also known as Chronic Obstructive Pulmonary Disease (COPD).
For those attending ATS, the two presentations are available as follows:
-- "Nebulized Formoterol is an Effective Bronchodilator and Improves the
Quality of Life for COPD Patients," Poster Board #A10, ...
- FDA Approves Dey, L.P.'s Perforomist(TM) (Formoterol Fumarate) Inhalation...
- Press release article from: PR Newswire May 11, 2007 700+ words
...worldwide use. Perforomist(TM) Inhalation Solution is the first and only FDA...fumarate, Perforomist(TM) Inhalation Solution offers a new treatment...nebulizing with Perforomist(TM) Inhalation Solution twice a day - once in the...
- Mylan Inc. Subsidiary, Dey, L.P., Announces that Perforomist(TM) (Formoterol...
- Press release article from: PR Newswire October 8, 2007 700+ words
...companies. Perforomist(TM) Inhalation Solution is indicated for long...experience. Perforomist(TM) Inhalation Solution is the first and only FDA...helpful that Perforomist(TM) Inhalation Solution offers a twice-daily...
- New Data on Perforomist(TM) Inhalation Solution to be Presented at CHEST 2008.
- Press release article from: PR Newswire October 24, 2008 700+ words
...with use of Perforomist(TM) Inhalation Solution - NAPA, Calif., Oct...results for Perforomist(TM) Inhalation Solution, twice daily via nebulization...MDI). Perforomist(TM) Inhalation Solution is approved for long...
- Data from Three Clinical Trials for Perforomist(TM) Inhalation Solution to be...
- Press release article from: PR Newswire October 16, 2007 700+ words
...FDA) for Perforomist(TM) Inhalation Solution. The third presents results...concomitant use of Perforomist(TM) Inhalation Solution with tiotropium for the...of COPD. Perforomist(TM) Inhalation Solution is the first and only FDA...
- Clinical Trial Data for Perforomist(TM) Inhalation Solution to be Presented at...
- Press release article from: PR Newswire May 16, 2008 700+ words
...symptoms of using Perforomist(TM) Inhalation Solution, nebulized formoterol fumarate...research results. About Perforomist(TM) Inhalation Solution Indication Perforomist(TM) Inhalation Solution is indicated for the long-term...
- Critical Therapeutics and Dey, L.P. Launch Perforomist(TM) (Formoterol...
- Press release article from: Business Wire October 8, 2007 700+ words
...NYSE: MYL). Perforomist[TM] Inhalation Solution is indicated for long-term, twice...United States. About Perforomist[TM] Inhalation Solution Indication Perforomist[TM] Inhalation Solution is indicated for the long-term...
- Nebulized Perforomist(TM) Inhalation Solution Provided Prolonged...
- Newspaper article from: Clinical Trials Week November 10, 2008 700+ words
...treatment with Perforomist(TM) Inhalation Solution nebulized formoterol fumarate...twice-daily Perforomist(TM) Inhalation Solution, nebulized FFIS, compared...with either Perforomist(TM) Inhalation Solution or albuterol/ipratropium...
- Clinical Trial Data for Perforomist(TM) (Formoterol Fumarate) Inhalation...
- Press release article from: PR Newswire May 21, 2007 700+ words
...found that Perforomist(TM) Inhalation Solution, a twice-daily, long...treatment between Perforomist(TM) Inhalation Solution and the active comparator...found that Perforomist(TM) Inhalation Solution was well tolerated, had...